Page 302 - Biodegradable Polyesters
P. 302

280  11  Electrospun Biopolymer Nanofibers and Their Composites for Drug Delivery Applications

                   PLGA randomly-oriented nanofiber  120  PLGA aligned nanofiber
           Drug release ratio (%) 140  PLGA/Gelatin (9/1) film  Drug release ratio (%) 140  PLGA/Gelatin (9/1) aligned nanofiber
                   PLGA film
                                                         PLGA randomly-oriented nanofiber
                   PLGA/Gelatin (9/1) randomly-oriented nanofiber
                                                         PLGA/Gelatin (9/1) randomly-oriented nanofiber
            120
                                                  100
            100
             80
                                                   80
             60
                                                   60
             40
                                                   20
             20                                    40
              0                                     0
               0    300  600   900  1200  1500       0    400    800   1200  1600
          (a)              Time (min)          (b)               Time (min)
                    Figure 11.3 Release curves of FBF from  PLGA/gelatin (9/1) electrospun nanofibers (b).
                    FBF-loaded PLGA and PLGA/gelatin (9/1)  (Reproduced with permission from Ref. [37];
                    electrospun nanofibers and solvent-cast films Copyright 2011 Elsevier.)
                    (a), aligned and randomly oriented PLGA and
                      Buschle-Diller et al. [39] focused on the preparation of PLA and PCL as well
                    as bicomponent fibers of PLA and PCL incorporating three different model
                    antibiotics. Since PCL almost completely liberated any of the drugs over time
                    while PLA only released about 10%, release characteristics could be modified
                    to fit a sensible drug delivery by forming bicomponent PCL–PLA fibers. Natu
                    et al. [40] reported electrospun bicomponent fibers of two semicrystalline
                    polymers, PCL and poly(oxyethylene-b-oxypropylene) for controlled drug release
                    applications. The release kinetics and regression analysis results implied a
                    three-stage release mechanism: the first stage was dissolution of the crystalline
                    drug that was not totally encapsulated in the fibers, followed by erosion (for
                    bicomponent fibers) or drug desorption and subsequent diffusion through
                    water-filled pores of PCL fibers, while the last stage was controlled by poly-
                    mer degradation. Since the components and stimuli-responsive properties of
                    fibers are important factors influencing their drug release behavior, Lin et al.
                    aimed at fabricating thermo-responsive poly(N-isopropylacrylamide) (PNI-
                    PAAm)/polyurethane (PU) nanofibers using a single-spinneret electrospinning
                    technique. The electrospun nanofibers were used as drug carriers by co-spinning
                    with nifedipine (NIF) and the release behavior of NIF can be effectively controlled
                    by adjusting the temperature of environment surrounding the thermo-responsive
                    nanofibers [41].


                    11.2.3
                    Drug-Loaded Nanoparticle/Biopolymer Composites

                    Owing to the high pore volumes for storage and delivery of drugs, as well as their
                    excellent photoluminescence properties, mesoporous materials functionalized
                    with photoluminescence show great potential applications in fields of controlled
                    drug delivery, disease diagnosis, and therapy. Luminescent, mesoporous, and
   297   298   299   300   301   302   303   304   305   306   307